Large-scale testing (Phase 3)Active Not RecruitingNCT03836261
What this trial is testing
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
Who this might be right for
Chronic Lymphocytic Leukemia
Acerta Pharma BV 984